ArticleOncotarget2017

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.

Lingyan Ping et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.